Prentice Ross L, Caan Bette, Chlebowski Rowan T, Patterson Ruth, Kuller Lewis H, Ockene Judith K, Margolis Karen L, Limacher Marian C, Manson JoAnn E, Parker Linda M, Paskett Electra, Phillips Lawrence, Robbins John, Rossouw Jacques E, Sarto Gloria E, Shikany James M, Stefanick Marcia L, Thomson Cynthia A, Van Horn Linda, Vitolins Mara Z, Wactawski-Wende Jean, Wallace Robert B, Wassertheil-Smoller Sylvia, Whitlock Evelyn, Yano Katsuhiko, Adams-Campbell Lucile, Anderson Garnet L, Assaf Annlouise R, Beresford Shirley A A, Black Henry R, Brunner Robert L, Brzyski Robert G, Ford Leslie, Gass Margery, Hays Jennifer, Heber David, Heiss Gerardo, Hendrix Susan L, Hsia Judith, Hubbell F Allan, Jackson Rebecca D, Johnson Karen C, Kotchen Jane Morley, LaCroix Andrea Z, Lane Dorothy S, Langer Robert D, Lasser Norman L, Henderson Maureen M
Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Wash 98109, USA.
JAMA. 2006 Feb 8;295(6):629-42. doi: 10.1001/jama.295.6.629.
The hypothesis that a low-fat dietary pattern can reduce breast cancer risk has existed for decades but has never been tested in a controlled intervention trial.
To assess the effects of undertaking a low-fat dietary pattern on breast cancer incidence.
A randomized, controlled, primary prevention trial conducted at 40 US clinical centers from 1993 to 2005.
A total of 48,835 postmenopausal women, aged 50 to 79 years, without prior breast cancer, including 18.6% of minority race/ethnicity, were enrolled.
Women were randomly assigned to the dietary modification intervention group (40% [n = 19,541]) or the comparison group (60% [n = 29,294]). The intervention was designed to promote dietary change with the goals of reducing intake of total fat to 20% of energy and increasing consumption of vegetables and fruit to at least 5 servings daily and grains to at least 6 servings daily. Comparison group participants were not asked to make dietary changes.
Invasive breast cancer incidence.
Dietary fat intake was significantly lower in the dietary modification intervention group compared with the comparison group. The difference between groups in change from baseline for percentage of energy from fat varied from 10.7% at year 1 to 8.1% at year 6. Vegetable and fruit consumption was higher in the intervention group by at least 1 serving per day and a smaller, more transient difference was found for grain consumption. The number of women who developed invasive breast cancer (annualized incidence rate) over the 8.1-year average follow-up period was 655 (0.42%) in the intervention group and 1072 (0.45%) in the comparison group (hazard ratio, 0.91; 95% confidence interval, 0.83-1.01 for the comparison between the 2 groups). Secondary analyses suggest a lower hazard ratio among adherent women, provide greater evidence of risk reduction among women having a high-fat diet at baseline, and suggest a dietary effect that varies by hormone receptor characteristics of the tumor.
Among postmenopausal women, a low-fat dietary pattern did not result in a statistically significant reduction in invasive breast cancer risk over an 8.1-year average follow-up period. However, the nonsignificant trends observed suggesting reduced risk associated with a low-fat dietary pattern indicate that longer, planned, nonintervention follow-up may yield a more definitive comparison.
ClinicalTrials.gov Identifier: NCT00000611.
低脂饮食模式可降低乳腺癌风险这一假设已存在数十年,但从未在对照干预试验中得到验证。
评估采用低脂饮食模式对乳腺癌发病率的影响。
1993年至2005年在美国40个临床中心进行的一项随机对照一级预防试验。
共招募了48835名50至79岁、无乳腺癌病史的绝经后女性,其中少数种族/族裔占18.6%。
女性被随机分配到饮食调整干预组(40%[n = 19541])或对照组(60%[n = 29294])。干预旨在促进饮食改变,目标是将总脂肪摄入量降至能量的20%,将蔬菜和水果的摄入量增加至每日至少5份,谷物摄入量增加至每日至少6份。对照组参与者未被要求改变饮食。
浸润性乳腺癌发病率。
与对照组相比,饮食调整干预组的膳食脂肪摄入量显著降低。两组从基线开始脂肪能量百分比变化的差异从第1年的10.7%到第6年的8.1%不等。干预组的蔬菜和水果摄入量每天至少多1份,谷物摄入量的差异较小且更短暂。在平均8.1年的随访期内,干预组发生浸润性乳腺癌的女性人数(年化发病率)为655人(0.42%),对照组为1072人(0.45%)(风险比,0.91;两组比较的95%置信区间,0.83 - 1.01)。二次分析表明,依从性好的女性风险比更低,为基线时高脂饮食的女性提供了更强的风险降低证据,并表明饮食效果因肿瘤的激素受体特征而异。
在绝经后女性中,在平均8.1年的随访期内,低脂饮食模式并未使浸润性乳腺癌风险在统计学上显著降低。然而,观察到的非显著趋势表明低脂饮食模式与风险降低相关,这表明更长时间、有计划的非干预随访可能会得出更明确的比较结果。
ClinicalTrials.gov标识符:NCT00000611。